Simultaneous determination of lamivudine, stavudine and nevirapine in antiretroviral fixed dose combinations by high performance liquid chromatography

Analytica Chimica Acta

Volumn 570, Issue 1, 2006, Pages 41-45

  Kapoor, Namita ^a   Khandavilli, Sateesh ^a   Panchagnula, Ramesh ^a  

^a NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

Fixed dose combinations (FDCs); HPLC; Lamivudine (3TC); Nevirapine (NVP); Stavudine (d4T)

Indexed keywords

ENZYME INHIBITION; ENZYMES; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METHANOL; PHARMACODYNAMICS; SEPARATION;

FIXED DOSE COMBINATIONS (FDCS); HPLC; LAMIVUDINE (3TC); NEVIRAPINE (NVP); STAVUDINE (D4T);

DRUG PRODUCTS;

2 PROPANOL; ACETIC ACID; ACETONITRILE; ANTIRETROVIRUS AGENT; EXCIPIENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE; METHANOL; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACCURACY; ARTICLE; CALIBRATION; COLUMN CHROMATOGRAPHY; DRUG DETERMINATION; FLOW RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PH MEASUREMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; ULTRAVIOLET RADIATION;

EID: 33646802664     PISSN: 00032670     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.aca.2006.03.107     Document Type: Article

References (14)

1. Panchagnula R., Agrawal S., Ashokraj Y., Varma M.V.S., Sateesh K., Bhardwaj V., Bedi S., Gulati I., Parmar J., Kaul C., Blomberg B., Fourie B., Roscigno G., Wire R., Laing R., Evans P., and Moore T. Methods Find. Exp. Clin. Pharmacol. 26 (2004) 703-721
2. FDA, 2004. Guidance for Industry. Fixed Dose Combination and Co-packaged Drug Products for treatment of HIV.
3. Raffanti S., and Haas D. Antimicrobial Agents: Antiretroviral Agents (1990), McGraw-Hill, New York
4. Anonymous, Indian Pharmacopoeia 1996 (Addendum 2002). Govt. of India, Ministry of health and family welfare. Published by Controller of Publications, Delhi, pp. 919-921.
5. Anonymous, Indian Pharmacopoeia 1996 (Addendum 2002). Govt. of India, Ministry of health and family welfare. Published by Controller of Publications, Delhi, pp. 913-914.
6. Kaul N., Agrawal H., Paradkar A., and Mahadik K. Talanta 62 (2004) 843-852
7. Kaul S., Stouffer B., Mummaneni V., Turabi N., Mantha S., Jayatilak P., and Barbhaiya R. J. Pharm. Biomed. Anal. 15 (1996) 165-174
8. Rezk N., Tidwell R., and Kashuba A. J. Chromatogr. B 791 (2003) 127-147
9. Simon V., Thiam M., and Lipford L. J. Chromatogr. A 913 (2001) 447-453
10. Aymard G., Legrand M., Trichereau N., and Diquet B. J. Chromatogr. B 744 (2000) 227-240
11. Notari S., Bocedi A., Ippolito G., Narciso P., Pucillo L.P., Tossini G., Donnorso R.P., Gasparrini F., and Ascenzi P. J. Chromatogr. B 831 (2006) 258-266
12. Anonymous, 2003. ICH Guideline Q2B.
13. Varma M.V.S., Kapoor N., Sarkar M., and Panchagnula R. J. Chromatogr. B 813 (2004) 347-352
14. Kasim N.A., Whitehouse M., Ramachandran C., Bermejo M., Lennernas H., Hussain A.S., Junginger H.E., Stavchansky S.A., Midha K.K., Shah V.P., and Amidon G.L. Mol. Pharm. 1 (2004) 85-96